CommercialCoverageMedium impact
New policies
Blue Cross Blue Shield of Rhode Island·RI · Oncology, Dermatology, General Surgery +2 more·Physician / Facility
Effective date
Aug 1, 2019
We identified it
Jun 20, 2026
Summary
BCBS Rhode Island has created three new medical policies effective August 1, 2019: Cryosurgical Ablation of Miscellaneous Solid Tumors (excluding renal, liver and prostate), Gamifant™ (emapalumab-lzsg) treatment, and ST2 Assay for heart failure and transplant rejection monitoring. Billing teams must review the full policy texts for specific coverage criteria and requirements.
Action Required
Immediately: Billing team must access bcbsri.com Provider section under Medical Policy heading to review full text of three new policies for specific billing requirements, coverage criteria, and documentation needs for cryosurgical ablation procedures, Gamifant treatments, and ST2 assays. Update billing protocols and prior authorization workflows as specified in each policy.